Clinical benefits of epoetin alfa (Eprex®) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy

Journal of the Medical Association of Thailand

Volumn 88, Issue 5, 2005, Pages 607-612

  Voravud, Narin ^a   Sriuranpong, Virote ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anemia; Cancer; Epoetin

Indexed keywords

CISPLATIN; FERROUS SULFATE; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROPOIESIS; FEMALE; FLU LIKE SYNDROME; HEMOGLOBIN DETERMINATION; HUMAN; LIFE EXPECTANCY; MALE; QUALITY OF LIFE; THAILAND;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATINICS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; THAILAND; TREATMENT OUTCOME;

EID: 23044447751     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. Am J Clin Oncol 1993; 16: 22-5.
2. Dalton JD, Bailey NP, Barrett-Lee PJ, O'Brien MER. Multicenter UK audit of anemia in patients receiving chemotherapy. Proc Am Soc Clin Oncol 1998; 17: 418a, (Abstr 1611).
3. Winningham ML, Nail LM, Barton Burke M, Brophy L, Cimprich B, Jones L, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 1994; 21: 23-36.
4. Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 1998; 25(Suppl 7): 43-6.
5. Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998; 25(Suppl 7): 2-6.
6. Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693-9.
7. Abel RI. Recombinant human erythropoietin in the treatment of the anemia of cancer. Acta Haematol 1992; 87(Suppl 1): 4-11.
8. Abels R. Erythropoietin for anemia in cancer patients Eur J Cancer 1993; 29A(Suppl 2): S2-8.
9. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-92.
10. Henry D. Supplemental iron: a key to optimizing the response of cancer related anemia to rHuEPO? Oncologist 1998; 3: 275-8.
11. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16: 3412-25.
12. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997; 15: 1218-34.
13. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guideline of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002; 20: 4083-107.
14. Littlewood TJ, Bajetta E, Nortier JWR, Vercammen E, Rapoport B. Effect of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19: 2865-74.
15. Cascinu S, Fedeli A, Del Ferro E, Luzi Fedeli S, Catalano G. Recombinant human erythropoietin treatment in cispatin-associated anemia: a randomized, double-blind trial with placebo. J Clin Oncol 1994; 12: 1058-62.
16. Kurz C, Marth C, Windbichler G, Lahousen M, Medl M, Vavra N, et al. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized double-blind placebo-controlled multicenter study. Gynecol Oncol 1997; 65: 461-6.